Polaris Capital Management, LLC

Position in EXEL — Exelixis, Inc.

CIK 1316926 BOSTON, MA

Position in EXEL

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$1,430,983

+$302,976 QoQ

Shares Held

26,300

0.0% QoQ

Ownership

0.011%

of shares outstanding

% of Portfolio

0.14%

of 13F equity value

Holder Rank

#305

of 754 holders

Holding Since

Jun 2022

17 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Polaris Capital Management, LLC holds $104,753,532 across 4 Biotechnology names. EXEL ranks #3 (1.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JAZZ	Jazz Pharmaceuticals plc	328,966	$79,270,937
2	CYTK	Cytokinetics Inc	266,900	$22,737,211
3	EXEL	Exelixis, Inc. This page	26,300	$1,430,983
4	HRMY	Harmony Biosciences Holdings, Inc.	36,100	$1,314,401

17 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,430,983	26,300	0.0%	Shares	Sole	2026-07-27
2026-03-31	$1,128,007	26,300	0.0%	Shares	Sole	2026-04-27
2025-12-31	$1,152,729	26,300	0.0%	Shares	Sole	2026-01-29
2025-09-30	$1,086,190	26,300	0.0%	Shares	Sole	2025-10-27
2025-06-30	$1,159,304	26,300	-37.5%	Shares	Sole	2025-07-21
2025-03-31	$1,554,332	42,100	-6.4%	Shares	Sole	2025-05-14
2024-12-31	$1,498,500	45,000	-27.3%	Shares	Sole	2025-01-29
2024-09-30	$1,606,305	61,900	0.0%	Shares	Sole	2024-11-13
2024-06-30	$1,390,893	61,900	0.0%	Shares	Sole	2024-07-26
2024-03-31	$1,468,887	61,900	0.0%	Shares	Sole	2024-04-24
2023-12-31	$1,484,981	61,900	-22.5%	Shares	Sole	2024-02-07
2023-09-30	$1,745,815	79,900	0.0%	Shares	Sole	2023-10-30
2023-06-30	$1,526,889	79,900	0.0%	Shares	Sole	2023-07-31
2023-03-31	$1,550,859	79,900	0.0%	Shares	Sole	2023-05-03
2022-12-31	$1,281,596	79,900	+85.8%	Shares	Sole	2023-02-09
2022-09-30	$674,240	43,000	-78.5%	Shares	Sole	2022-11-10
2022-06-30	$4,164,000	200,000	—	Shares	Sole	2022-08-10
No filing history on record for this holder in this stock.